Combating hypoxemia in COVID-19 patients with a natural oxygen carrier, HEMO(2)Life® (M101)

BACKGROUND: Infection with SARS-CoV-2 is responsible for the COVID-19 crisis affecting the whole world. This virus can provoke acute respiratory distress syndrome (ARDS) leading to overcrowed the intensive care unit (ICU). Over the last months, worldwide experience demonstrated that the ARDS in COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Lupon, Elise, Lellouch, Alexandre G., Zal, Franck, Cetrulo, Curtis L., Lantieri, Laurent A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685057/
https://www.ncbi.nlm.nih.gov/pubmed/33308935
http://dx.doi.org/10.1016/j.mehy.2020.110421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685057/
https://www.ncbi.nlm.nih.gov/pubmed/33308935
http://dx.doi.org/10.1016/j.mehy.2020.110421

Ejemplares similares